Sana Biotechnology
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,391 | -3,053 | ||
EBITDA | 18,506 | -61,401 | -44,819 | -55,772 |
EBIT | 18,506 | -63,635 | -47,210 | -58,825 |
Net Income | 20,401 | -63,635 | -47,210 | -58,825 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -39,543 | -34,411 | -37,667 | -33,514 |
Cash | 41,104 | 57,073 | 83,800 | 71,870 |
Basic Shares | 308,790 | 295,667 | 276,856 | 253,234 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12,750 | -15,491 | -30,865 | -27,731 |
EBITDA | -231,416 | -251,259 | -258,698 | -256,939 |
EBIT | -244,166 | -266,759 | -283,255 | -272,564 |
Net Income | -244,166 | -266,759 | -283,255 | -266,388 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -74,575 | |||
Free Cash Flow | -144,766 | -256,583 | -273,614 | -310,926 |
Cash | 71,870 | 127,566 | 133,517 | 176,765 |
Basic Shares | 253,234 | 230,891 | 194,541 | 188,344 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.14 |
2026-06-30 | -$0.13 |
2026-03-31 | -$0.14 |
2025-12-31 | -$0.16 |